ArticleEco-Environment & Health2026
Molecular insights into the selective separation of perfluoroalkyl substances: The construction and application of capsule adsorbents.
Article in Eco-Environment & Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perfluoroalkyl substances (PFAS) pollution has been a worldwide environmental challenge. Inspired by the semipermeable function of cell membranes, we constructed a millimeter-sized capsule adsorbent with specific molecular recognition capability to capture a broad spectrum of PFAS. This novel capsule consists of a core with a regulated nanoscale amine-rich network powder (ANP) and a porous polyvinylidene fluoride (PVDF) shell. Adsorption experiments and molecular simulations revealed that the PVDF shell acted as a semipermeable membrane, allowing only PFAS to pass through while repelling the coexisting environmental matrices, whereas the ANP core could provide the driving force for PFAS to enter the interior of the capsule adsorbent. Moreover, by regulating the hydrophilic functional structure of ANP, the driving force for short-chain PFAS to enter the capsule interior was enhanced, enabling the efficient capture of a wide range of PFAS (C-F number: 3-9). Further mechanistic studies demonstrated that the dual driving forces based on fluorophilicity and hydrogen bonding were key to capturing broad-spectrum PFAS. The fixed-bed experiments further demonstrated that the aminated organic fluorine capsule (AFC) column could treat approximately 18,000 bed volumes of effluent from synthetic PFOA-polluted water, with the effluent PFOA concentration remaining below 40 ng/L from an initial influent concentration of 1 μg/L (compared with the World Health Organization's drinking-water standard of 100 ng/L). Overall, this work not only provides a promising approach to treat PFAS-containing water but also sheds light on the design of functional remediation materials based on molecular properties and confined structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.